InsidersTradesSigma
Biora Therapeutics, INC.: management transactions · United States · SEC (Form 4)
SEC:biora-therapeutics-inc-7d3054US·SEC (Form 4)Mcap 777.3Bn€Technology
Browse the full insider trade history of Biora Therapeutics, INC., a publicly traded company based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Operating in the Technology sector, Biora Therapeutics, INC. has logged 8 insider filings. Market capitalisation: €777.3bn. The latest transaction was filed on 17 June 2022 (Attribution). Among the most active insiders: Kotzin Brian L.. All data is free.
8
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended August 2025 · cache
Analyst consensus
41 analystsStrong buy
249.00 €Target 584.24 €1000.00 €
Income statement
Revenue37.38 Bn€
Gross profit14.87 Bn€40% margin
Net income8.54 Bn€41.5% margin
Valuation
PER (trailing)32.6x
PER (forward)6.7x
P/Book10.7x
Beta1.92
Balance sheet & cash
Market cap777.35 Bn€
Total debt15.28 Bn€
Free Cash Flow1.67 Bn€
Debt / Equity15%
Profitability & ownership
ROE39.8%
ROA20.1%
% insiders0.3%
% institutions81.1%
Last declaration on 17 June 2022
Declarations8 total
Executives◆Grant16SEC
096,154 shares0
Common Stock
SEC:0000899243-22-023091:0·
Executives●Retenue fiscale15SEC
€5,9898,305 shares@ €0.72110.0000% mcap100.0% of flow
Common Stock
SEC:0000899243-22-018432:0·
Executives●Retenue fiscale32SEC
€7,49010,387 shares@ €0.72110.0000% mcap100.0% of flow
Common Stock
SEC:0000899243-22-018428:0·
Executives◆Grant27SEC
01,562,500 shares0
Common Stock
SEC:0000899243-22-018429:0·
8 of 8 declarations